← SynDRA
MIRANSERTIB
SynDRA canonical compound SYN0039413 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AKT2 |
|---|
| Mechanism of action | AKT inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- AKT2 INHIBITOR
- Serine/threonine-protein kinase AKT inhibitor
- AKT3 INHIBITOR
- AKT1 INHIBITOR
- AKT3 MODULATOR
Cross-references
Synonyms
- ARQ-092
- ARQ 092 FREE BASE
- ARQ092
- ARQ092 FREE BASE
- ARQ 092
- T1DQI1B52Y
- WHO 10490
- miransertibum
- RefChem:818902
- AKT inhibitor 2
- ARQ 092 Free Base
- Miransertib [INN]
- Miransertib [USAN]
- Miransertib [WHO-DD]
- MFCD30187510
- Miransertib (USAN/INN)
- ARQ-092(Miransertib)?
- Miransertib (ARQ-092)
- UNII-T1DQI1B52Y
- GTPL9429
- orb1304175
- SCHEMBL2175958
- SCHEMBL2187875
- SCHEMBL29372652
- SCHEMBL30086167
- HNFMVVHMKGFCMB-UHFFFAOYSA-N
- GLXC-10662
- Miransertib [USAN:INN:WHO-DD]
- C27H24N6
- EX-A1268
- BDBM50536167
- BDBM50593633
- NSC791328
- AKOS030526404
- CS-5377
- EBC-190035
- NSC-791328
- SB19688
- compound 21a [PMID: 27305487]
Look up MIRANSERTIB in the interactive SynDRA portal →